CUSIP 641288105COMNPCEQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
99 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Polar Capital Holdings PLC | 2.88M | $44.44M | −219.3K | Reduced |
| 2 | Soleus Capital Management, L.P. | 2.70M | $41.74M | −254.7K | Reduced |
| 3 | Morgan Stanley | 2.55M | $39.34M | +1.6K | Added |
| 4 | Orbimed Advisors LLC | 2.41M | $37.15M |
| −207.8K |
| Reduced |
| 5 | Blackrock, Inc. | 2.38M | $36.81M | −32.7K | Reduced |
| 6 | Driehaus Capital Management LLC | 1.51M | $23.33M | +571.8K | Added |
| 7 | Vanguard Group Inc | 1.48M | $22.89M | +46.4K | Added |
| 8 | First Light Asset Management, LLC | 1.35M | $20.84M | −10.6K | Reduced |
| 9 | Deutsche Bank AG\ | 929.5K | $14.35M | +756 | Added |
| 10 | Armistice Capital, LLC | 792.0K | $12.23M | −506.0K | Reduced |
See every fund holding Neuropace Inc, with full quarter-over-quarter share changes.
Unlock all holders